REGULATORY AGENCY ACTION
health agency providing hospice care may
be dispensed upon an oral prescription. [S.
Jud]

■ FUTURE MEETINGS
To be announced.

BOARD OF OPTOMETRY
Executive Officer: Karen Ollinger
(916) 323-8720

ursuant to Business and Professions
PCode
section 3000 et seq., the Board
of Optometry is responsible for licensing
qualified optometrists and disciplining
malfeasant practitioners. The Board establishes and enforces regulations pertaining
to the practice of optometry, which are
codified in Division 15, Title 16 of the
California Code of Regulations (CCR).
The Board's goal is to protect the consumer patient who might be subjected to
injury resulting from unsatisfactory eye
care by inept or untrustworthy practitioners. The Board consists of nine members-six licensed optometrists and three
public members.

■ MAJOR PROJECTS
Board Proposes Regulatory
Changes. At its February 18 meeting, the
Board authorized staff to commence the
rulemaking process to amend sections
1502 (delegation of functions), 1510 (professional inefficiency), and 1535 (examination results), and to adopt new sections
1566 (release of prescriptions: notice required), Division 15, Title 16 of the CCR.
Section 1502 currently delegates and
confers upon the Board Secretary or, in
his/her absence from the Board's office,
the Executive Officer, enforcement-related functions involving the filing of accusations, issuing notices of hearings,
statements to respondents, statements of
issues, and other powers and duties conferred by law to the Board. The Board's
proposed amendment would delete the
role of the Board Secretary in these matters, and instead delegate those enforcement functions to the Board's Executive
Officer.
Business and Professions Code section
3090 authorizes the Board to revoke or
suspend an optometrist's certificate of
registration for unprofessional conduct,
gross ignorance, or inefficiency in his/her
profession. Proposed amendments to section 1510 would provide that-among
other things-inefficiency in the profession is indicated by the failure to inform

any patient for whom treatment is prescribed, in terms understandable to that
patient (or legal guardian, if appropriate),
of the risks and benefits of the treatment.
Currently, the Board requires applicants examination for certificates of registration as optometrists to successfully
complete the National Board Examination
in Optometry as a condition of eligibility
to take the Board's examination. Proposed
amendments to section 1535 would provide that applicants for licensure must successfully complete the National Board
Exam, the Board's practical exam, and the
Board's law exam, and that applicants
may fulfill these requirements in any sequence. However, the amendment states
that in no case shall the total period in
which the requirements are met exceed
five years.
Finally, proposed new section 1566
would provide that each optometry office
shall post in a conspicuous place a notice
which clearly states the legal requirements
and office policy regarding the release of
eyeglass and contact lens prescriptions.
[ 13:1 CRLR 59] The Board published notice of its intent to pursue these regulatory
changes and, at this writing, is scheduled
to hold a public hearing on the proposals
on May 20 in San Diego.
In other rulemaking action, the Board
decided at its February meeting not to
attempt to overrule Department of Consumer Affairs (DCA) Director Jim
Conran's rejection of its proposed amendments to section 1533 and repeal of section 1533.1, which would abolish the
Board's examination appeal process.
[ 13: 1 CRLR 59J Instead, the Board will
work with DCA's Central Testing Unit to
arrive at an acceptable examination appeal
process.
UCLA Optometry Refresher Course
Update. The final segment of the optometry refresher course, designed by the
Board in conjunction with UCLA, concluded in April. [ 13: 1 CRLR 60; 12:4
CRLR JJ4] Students completing both the
first segment on basic science and the
second clinical segment participated in a
May graduation ceremony at UCLA.
Funding for the course was earmarked by
the state for just one year; at this writing,
there are no plans to repeat the course.
Disclaimer Planned for Continuing
Education. At its February 18-19 meeting, the Board agreed to require all continuing education (CE) providers to provide
a written or oral disclaimer clarifying
whether participation in the course is for
"information only," or whether the course
qualifies the individual to perform a certain procedure. In recent disciplinary actions, optometrists have contended that
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they believed a particular procedure was
within the scope of optometry in California because it was the subject of a Boardapproved CE course. The disclaimer
would clarify that participants in CE
classes retain personal responsibility to
verify whether state law allows the individual to include the procedure in his/her
practice.

■ LEGISLATION
AB 1894 (Polanco), as introduced
March 5, would authorize ancillary personnel who work under the supervision of
an optometrist to assist in the preparation
of the patient and the preliminary collection of data. The bill would prohibit an
optometrist from permitting ancillary personnel to collect data requiring the exercise of professional judgment or skill of an
optometrist, perform any subjective refraction procedures, contact tonometry,
data analysis, or diagnosis, or prescribe
and determine any treatment plan. [A.
Health]
AB 2020 (Isenberg), as amended May
19, would provide that the practice of optometry includes, among other things, the
examination of the human eye, or its appendages and adnexa, and the analysis and diagnosis of conditions of the human vision system, either subjectively or objectively. This
bill would delete an existing requirement
that the Board designate pharmaceutical
agents which may be used by optometrists
in examining the human eye and instead
authorize the use of specified diagnostic
pharmaceutical agents. It would also authorize the use, prescribing, and dispensing of
specified therapeutic pharmaceutical agents
to a patient by an optometrist for the purposes of treating the human eye, or its appendages or adnexa, for any disease or
pathological condition by an optometrist
who meets specified requirements. The bill
would establish a seven-member pharmaceutical advisory committee with a prescribed membership to provide advice to the
Board as to the use of diagnostic and therapeutic agents. Under this bill, only optometrists who meet several examination and
training requirements and agree to accept
Medi-Cal patients are permitted to use, dispense, or prescribe therapeutic pharmaceutical agents. AB 2020 would also make it a
misdemeanor for any person licensed as an
optometrist to refer a patient to a pharmacy
that is owned by the licensee or in which the
licensee has proprietary interest. This bill is
sponsored by the California Optometric Association and is opposed by the California
Medical Association. [A. Floor]
SB 908 (Calderon), as introduced
March 4, would provide that the terms
"license" and "certificate of registration"
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are deemed to be synonymous for the purposes of the provisions of law regarding
the Ii censure and regulation of optometry.
[S. B&PJ

SB 921 (Maddy), as introduced March
4, would provide that it is unprofessional
conduct for an optometrist to fail to advise
a patient in writing of any pathology that
requires the attention of a physician when
an examination of the eyes indicates a
substantial likelihood of any pathology.
[S. B&PJ

SB 842 (Presley), as amended April
13, would authorize the Board to issue
interim orders of suspension and other
license restrictions, as specified, against
its licensees. [A. CPGE&EDJ

■ LITIGATION
In California Optometric Association
(COA) v. Division of Allied Health Professions, Medical Board of California,
No. 531542 (filed January 11 in Sacramento County Superior Court), and Engineers and Scientists of California (ESC),
et al. v. Division of Allied Health Professions, Medical Board of California, No.
706751-0 (filed October 8, 1992 in Alameda County Superior Court), COA and
ESC challenge the validity of DAHP's
medical assistant regulations.
Following the enactment of SB 645
(Royce) (Chapter 666, Statutes of 1988),
it took DAHP over three years to adopt
section 1366, Title 16 of the CCR, its
regulation defining the technical support
services which unlicensed medical assistants (MAs) may perform and establishing
standards for appropriate MA training and
supervision. During the lengthy rulemaking process, DCA rejected DAHP's proposed regulations twice and the Office of
Administrative Law rejected them once
before finally approving them in March
1992.
During the rulemaking hearings, COA
and the Board of Optometry objected to
language in the proposed regulations stating that MAs are permitted to perform
"automated visual field testing, tonometry, or other simple or automated ophthalmic testing not requiring interpretation in
order to obtain test results, using machines
or instruments, but are precluded from the
exercise of any judgment or interpretation
of the data obtained on the part of the
operator." [ 12: 1 CRLR 88-89J However,
DAHP overruled the objections and included this language in its final regulations. COA and ESC claim that section
1366 is invalid because the conduct authorized is beyond the scope of DAHP's
authority and conflicts with DAHP's enabling statutes; further, it conflicts with
Business and Professions Code sections
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3040 and 3041 (which define the practice
of optometry and prohibit unlicensed persons from engaging in optometry). At this
writing, the Attorney General has filed an
answer on behalf of DAHP; no court hearing has been set.

■ RECENT MEETINGS
At the February 18 meeting, Executive
Officer Karen Ollinger reviewed previously-approved budget changes, and reported that the Board is close to covering
its costs. Ollinger also announced that the
occupational analysis by Human Resource
Strategies is proceeding on schedule.
[ 13: 1 CRLR 59J Finally, Board President
Thomas Nagy, OD, announced that Board
member Stephen R. Chun, OD, was
named Optometrist of the Year at the annual California Optometric Association
Congress.

■ FUTURE MEETINGS
November 17-18 in Orange County.

BOARD OF PHARMACY
Executive Officer: Patricia Harris
(916) 445-5014
ursuant to Business and Professions
PCode
section 4000 et seq., the Board
of Pharmacy grants licenses and permits
to pharmacists, pharmacies, drug manufacturers, wholesalers and sellers of hypodermic needles. It regulates all sales of
dangerous drugs, controlled substances
and poisons. The Board is authorized to
adopt regulations, which are codified in
Division 17, Title 16 of the California
Code of Regulations (CCR). To enforce its
regulations, the Board employs full-time
inspectors who investigate accusations
and complaints received by the Board.
Investigations may be conducted openly
or covertly as the situation demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized by
law to suspend or revoke licenses or permits for a variety of reasons, including
professional misconduct and any acts substantially related to the practice of pharmacy.
The Board consists of ten members,
three of whom are public. The remaining
members are pharmacists, five of whom
must be active practitioners. All are appointed for four-year terms.

■ MAJOR PROJECTS
Restructuring the Enforcement
Unit. As the Board has not augmented its

enforcement program in at least ten years,
it spent considerable time at its October
1992 meeting discussing the need to expand the program in light of the increasing
number of pharmacies and licensed pharmacists in California, the establishment of
new registration programs such as medical device retailers and pharmacy technicians, and changes in the law governing
the practice of pharmacy. [ 13: 1 CRLR 60]
At the Board's April 28-29 meeting,
Executive Officer Patricia Harris reported
that the Governor and the budget subcommittees in both houses of the legislature
have tentatively approved a $703,000 increase to the Board's 1993-94 budget to
establish eight additional enforcement
unit positions: five inspectors, one supervising inspector, one consumer services
representative, and one office technician.
The increase in staff will enable the Board
to establish a public assistance unit staffed
by complaint handlers to assist consumers
who call with questions regarding pharmacy services and pharmacists; complaints would be opened by this unit and
referred to the inspection staff for investigation. This process is expected to enable
Board inspectors to focus their efforts on
inspection, not compiaint processing.
Harris cautioned that the full legislature
has yet to pass the Governor's budget, and
that the budget augmentation may be revised or deleted.
Board Discusses Request for Regulatory Change. At its January 20-21
meeting, the Board noted that it had received several requests to revise section
1719(c), Title 16 of the CCR, which provides that, as of April 16, 1992, all candidates for the pharmacist licensure examination who are graduates of a foreign
pharmacy school (any school located outside the United States) must demonstrate
proficiency in English by achieving a
score of at least 220 on the Test of Spoken
English administered by the Educational
Testing Service. Board member Gilbert
Castillo noted that the issue was originally
discussed by the Board and referred to its
Competency Committee for evaluation;
the Committee held preliminary hearings
and invited public input. Following discussion, the Board unanimously agreed
that it is in the best interest of the consumer to continue to require that foreign
pharmacy graduates pass the Test of Spoken English.
Board Considers Electronic Transmission of Prescriptions. At the Board's
January 20-21 meeting, the Board's Committee on Electronic Transmission and
Faxing of Prescriptions recommended
that the Board pursue statutory and regulatory changes to allow for the electronic
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